she has done it again..., page-8

Another thing that hasn't changed is the meaning of speculative koparoma.

Not only is POH a spec stock it is also a bio,we are not drilling for gas here and clinical trials take time,plenty of it.

What great opportunities have fallen over here? None that I can think of to date.

How many other companies that have patented transdermal technology has CSL signed a research and option agreement with.

None that I can think of.

All of your 'gunna' points insinuate that POH is not actually furthering any of these products when in fact the opposite is the case.

I understand your frustration koparama,perhaps it is time to re-evaluate your goals with this stock if it causing you so much angst.

Good research on the coconut oil/insulin delivery,but 5 years ago-seems a long time to bring something to market:)